BIT:AMPHealthcare
Assessing Amplifon (BIT:AMP) Valuation After Margin Plan And Return To Positive Organic Growth
Amplifon (BIT:AMP) has drawn fresh attention after reporting full year 2025 results, with sales of €2,395.7 million and net income of €91.3 million, alongside a return to positive organic growth in the fourth quarter.
See our latest analysis for Amplifon.
The earnings release and World Hearing Day initiatives have not stopped Amplifon’s share price from coming under pressure. A 1 day share price return of 13.2% decline and a 1 year total shareholder return of 47.7% decline point to fading...